NATIONAL CANCER INSTITUTE - CANCER.GOV

Search Results for: HA-22 (Lymphoma)

Total Results Found: 8

Total Results Found: 8

Comparative Oncology Program (COP)
Bethesda, MD

Collaborative

The COP evaluates novel therapies in pet dogs with cancer to improve outcomes for human patients and established the Comparative Oncology Trial Consortium (COTC), a collaborative effort of NCI and extramural comparative oncology centers at 19 Read More...

Biopharmaceutical Development Program (BDP)
Frederick, MD

Collaborative

The Biopharmaceutical Development Program (BDP) provides resources for the development of investigational biological agents. The BDP supports feasibility through development and Phase I/II cGMP manufacturing plus regulatory documentation. BDP is a DCTD-dedicated facility, but Read More...

CLIA Molecular Diagnostics Laboratory
Frederick, Maryland

Core Facility

Mutation Detection:: For PCR and Sanger sequencing both testing and bioinformatics interpretation are conducted. This method is currently being used in patients with chronic granulomatous disease (CGD), WHIM syndrome, and other autoimmune disorders. Because Sanger Read More...

CCR Sequencing Facility
Frederick, MD

Core Facility

The introduction of DNA sequencing instruments capable of producing millions of DNA sequence reads in a single run has profoundly altered the landscape of genetics and cancer biology. Complex questions can now be answered at Read More...

NCI Cloud Resources
Rockville, MD

Collaborative

The NCI Cloud Resources are components of the NCI Cancer Research Data Commons (CRDC) that bring data and computational power together to enable cancer research and discovery. These cloud-based platforms eliminate the need for researchers Read More...

NCI Patient-Derived Models Repository (PDMR)
Bethesda, MD

Collaborative

The National Cancer Institute (NCI) is developing a national repository of Patient-Derived Models (PDMs) comprised of patient-derived xenografts (PDXs), in vitro patient-derived tumor cell cultures (PDCs) and cancer associated fibroblasts (CAFs) as well as patient-derived Read More...

Sequencing Facility

Web Page

[tabby title="Overview"] CCR Sequencing Facility Please Note: Due to the budget and personnel reduction, starting May 20th, 2024 and until further notice, the Sequencing Facility will no longer be providing the Single Cell Services listed Read More...